Meredith Halks Miller

Summary

Affiliation: Berlex Biosciences
Country: USA

Publications

  1. ncbi CCR1 is an early and specific marker of Alzheimer's disease
    Meredith Halks-Miller
    Pharmacopathology, Berlex Biosciences, 2600 Hilltop Drive, Richmond, CA 94804, USA
    Ann Neurol 54:638-46. 2003
  2. ncbi Urokinase-type plasminogen activator plays a critical role in angiotensin II-induced abdominal aortic aneurysm
    Gary G Deng
    Berlex Biosciences, Department of Pharmacology and Cardiovascular Research, PO Box 4099, 2600 Hilltop Dr, Richmond, Calif 94804 0099, USA j
    Circ Res 92:510-7. 2003
  3. pmc Thrombin-activatable fibrinolysis inhibitor (TAFI) deficiency is compatible with murine life
    Mariko Nagashima
    Department of Cardiovascular Research, Berlex Biosciences, Richmond, California 94804, USA
    J Clin Invest 109:101-10. 2002
  4. ncbi Reduction of cardiac functional reserve and elevation of aortic stiffness in hyperlipidemic Yucatan minipigs with systemic and coronary atherosclerosis
    Yi Xin Wang
    Department of Pharmacology, Berlex Bioscience, P O Box 4099, 600 Hilltop Blvd, Richmond, CA 94804 0099, USA
    Vascul Pharmacol 39:69-76. 2002
  5. ncbi Inhibition of Rho-kinase by fasudil attenuated angiotensin II-induced cardiac hypertrophy in apolipoprotein E deficient mice
    Yi Xin Wang
    Department of Pharmacology, Berlex Biosciences, 2600 Hilltop Drive, Richmond, CA 94804, USA
    Eur J Pharmacol 512:215-22. 2005
  6. ncbi Fasudil, a Rho-kinase inhibitor, attenuates angiotensin II-induced abdominal aortic aneurysm in apolipoprotein E-deficient mice by inhibiting apoptosis and proteolysis
    Yi Xin Wang
    Berlex Biosciences, Richmond, Calif 94804, USA
    Circulation 111:2219-26. 2005
  7. ncbi Identification of a novel prostate tumor target, mindin/RG-1, for antibody-based radiotherapy of prostate cancer
    Renate Parry
    Berlex Biosciences, Richmond, California 94806, USA
    Cancer Res 65:8397-405. 2005
  8. ncbi Angiotensin II induces histomorphologic features of unstable plaque in a murine model of accelerated atherosclerosis
    Valdeci Da Cunha
    Department of Pharmacology, Berlex Biosciences, Richmond, CA, USA
    J Vasc Surg 44:364-71. 2006

Collaborators

Detail Information

Publications8

  1. ncbi CCR1 is an early and specific marker of Alzheimer's disease
    Meredith Halks-Miller
    Pharmacopathology, Berlex Biosciences, 2600 Hilltop Drive, Richmond, CA 94804, USA
    Ann Neurol 54:638-46. 2003
    ..Thus, neuronal CCR1 is not a generalized marker of neurodegeneration. Rather, it appears to be part of the neuroimmune response to Abeta42-positive neuritic plaques...
  2. ncbi Urokinase-type plasminogen activator plays a critical role in angiotensin II-induced abdominal aortic aneurysm
    Gary G Deng
    Berlex Biosciences, Department of Pharmacology and Cardiovascular Research, PO Box 4099, 2600 Hilltop Dr, Richmond, Calif 94804 0099, USA j
    Circ Res 92:510-7. 2003
    ....
  3. pmc Thrombin-activatable fibrinolysis inhibitor (TAFI) deficiency is compatible with murine life
    Mariko Nagashima
    Department of Cardiovascular Research, Berlex Biosciences, Richmond, California 94804, USA
    J Clin Invest 109:101-10. 2002
    ..The current study demonstrates that TAFI deficiency does not change normal responses to acute challenges...
  4. ncbi Reduction of cardiac functional reserve and elevation of aortic stiffness in hyperlipidemic Yucatan minipigs with systemic and coronary atherosclerosis
    Yi Xin Wang
    Department of Pharmacology, Berlex Bioscience, P O Box 4099, 600 Hilltop Blvd, Richmond, CA 94804 0099, USA
    Vascul Pharmacol 39:69-76. 2002
    ..Thus, cardiac functional reserve measured by isoproterenol-stimulated responses was reduced in atherosclerotic minipigs, which was further diminished in diabetes...
  5. ncbi Inhibition of Rho-kinase by fasudil attenuated angiotensin II-induced cardiac hypertrophy in apolipoprotein E deficient mice
    Yi Xin Wang
    Department of Pharmacology, Berlex Biosciences, 2600 Hilltop Drive, Richmond, CA 94804, USA
    Eur J Pharmacol 512:215-22. 2005
    ..These data are consistent with a role for Rho-kinase activation in angiotensin II-induced cardiac remodeling and vascular wall fibrosis...
  6. ncbi Fasudil, a Rho-kinase inhibitor, attenuates angiotensin II-induced abdominal aortic aneurysm in apolipoprotein E-deficient mice by inhibiting apoptosis and proteolysis
    Yi Xin Wang
    Berlex Biosciences, Richmond, Calif 94804, USA
    Circulation 111:2219-26. 2005
    ..In this study, we tested the hypothesis that fasudil, a Rho-kinase inhibitor, could attenuate Ang II-induced AAA formation by inhibiting vascular wall apoptosis and extracellular matrix proteolysis...
  7. ncbi Identification of a novel prostate tumor target, mindin/RG-1, for antibody-based radiotherapy of prostate cancer
    Renate Parry
    Berlex Biosciences, Richmond, California 94806, USA
    Cancer Res 65:8397-405. 2005
    ..We conclude that [90Y]-CHX-A''-DTPA-19G9 is a novel antibody conjugate that has considerable promise for therapy of metastatic prostate cancer in androgen-unresponsive patients...
  8. ncbi Angiotensin II induces histomorphologic features of unstable plaque in a murine model of accelerated atherosclerosis
    Valdeci Da Cunha
    Department of Pharmacology, Berlex Biosciences, Richmond, CA, USA
    J Vasc Surg 44:364-71. 2006
    ..We explored the role of angiotensin II in determining the histomorphometric features of plaque stability in apolipoprotein E-deficient mice submitted to ligation of the carotid artery...